Heart rate and blood pressure responses to tobacco smoking among African-American adolescents

Eric T Moolchan, Darrell L Hudson, Jennifer R Schroeder, Shelley S Sehnert, Eric T Moolchan, Darrell L Hudson, Jennifer R Schroeder, Shelley S Sehnert

Abstract

Ethnic differences in both physiological response to and health consequences of tobacco smoking-some of which have been attributed to ethnic preferences for menthol cigarettes-have been described in the literature. We compared acute physiological responses to smoking in African-American and European-American adolescent menthol cigarette smokers seeking smoking cessation treatment. One-hundred- twenty-eight adolescents (32% African-American, 71% female; mean age 15.16 +/- 1.32 years, mean Fagerström Test of Nicotine Dependence (FTND) score 6.73 +/- 1.53, cigarettes per day (CPD) 16.9 +/- 2.64) participated in an experimental session during which they smoked one menthol cigarette of their usual brand. Blood pressure, heart rate, and exhaled carbon monoxide (CO) concentrations were measured before and after smoking; mean puff volume (mL), puff duration (sec) and maximal puff velocity (mL/sec) during smoking were also determined. Two sample t-tests were performed to assess ethnic differences in smoking topography; analysis of covariance was used to determine whether heart rate and blood pressure after smoking one menthol cigarette varied by ethnicity, after controlling for baseline physiological measures. No significant ethnic differences were observed in either smoking topography or acute cardiovascular response to smoking. These preliminary findings warrant extension to a broader group of nontreatment-seeking adolescent smokers of both ethnicities.

References

    1. Am Psychol. 1999 Oct;54(10):805-16
    1. Nicotine Tob Res. 2003 Oct;5(5):673-9
    1. Clin Chest Med. 2000 Mar;21(1):159-72
    1. J Am Acad Child Adolesc Psychiatry. 2000 Jun;39(6):682-93
    1. Nicotine Tob Res. 1999 Dec;1(4):317-24
    1. Nicotine Tob Res. 1999 Dec;1(4):357-64
    1. Psychopharmacology (Berl). 2001 Jan 1;153(2):249-57
    1. Addiction. 2001 Oct;96(10):1409-17
    1. Natl Vital Stat Rep. 2001 Sep 21;49(8):1-113
    1. Am J Public Health. 2002 Mar;92(3):437-42
    1. MMWR Morb Mortal Wkly Rep. 2002 May 17;51(19):409-12
    1. Arch Pediatr Adolesc Med. 2003 Jun;157(6):533-8
    1. Nicotine Tob Res. 2004 Feb;6 Suppl 1:S93-5
    1. Am Heart J. 1984 Sep;108(3 Pt 2):759-69
    1. Am J Public Health. 1990 Sep;80(9):1053-6
    1. Pharmacol Biochem Behav. 1990 Sep;37(1):29-39
    1. Br J Addict. 1991 May;86(5):589-92
    1. Br J Addict. 1991 Sep;86(9):1119-27
    1. Am J Public Health. 1991 Nov;81(11):1483-6
    1. Clin Investig. 1992 Mar-Apr;70(3-4):335-42
    1. J Pharm Pharmacol. 1994 Aug;46(8):618-30
    1. BMJ. 1997 Jun 28;314(7098):1860-3
    1. Am J Prev Med. 1998 Feb;14(2):130-7
    1. JAMA. 1998 Jul 8;280(2):135-9
    1. Addict Behav. 1999 Jan-Feb;24(1):1-16
    1. J Pharmacol Exp Ther. 1999 Oct;291(1):1-6
    1. Eur Respir J. 2000 Jan;15(1):177-80

Source: PubMed

3
Se inscrever